Annual Total Expenses:
$538.09M+$163.00M(+43.45%)Summary
- As of today, CORT annual total expenses is $538.09 million, with the most recent change of +$163.00 million (+43.45%) on December 31, 2024.
- During the last 3 years, CORT annual total expenses has risen by +$296.59 million (+122.81%).
- CORT annual total expenses is now at all-time high.
Performance
CORT Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Expenses:
$188.28M+$28.46M(+17.81%)Summary
- As of today, CORT quarterly total expenses is $188.28 million, with the most recent change of +$28.46 million (+17.81%) on September 30, 2025.
- Over the past year, CORT quarterly total expenses has increased by +$52.42 million (+38.59%).
- CORT quarterly total expenses is now at all-time high.
Performance
CORT Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CORT Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +43.5% | +38.6% |
| 3Y3 Years | +122.8% | +180.3% |
| 5Y5 Years | +176.1% | +191.0% |
CORT Total Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +122.8% | at high | +180.3% |
| 5Y | 5-Year | at high | +176.1% | at high | +236.4% |
| All-Time | All-Time | at high | +6621.1% | at high | +517.9% |
CORT Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $188.28M(+17.8%) |
| Jun 2025 | - | $159.82M(+16.7%) |
| Mar 2025 | - | $136.93M(-9.6%) |
| Dec 2024 | $538.09M(+43.5%) | $151.50M(+11.5%) |
| Sep 2024 | - | $135.86M(+5.6%) |
| Jun 2024 | - | $128.68M(+7.9%) |
| Mar 2024 | - | $119.29M(+14.4%) |
| Dec 2023 | $375.09M(+29.7%) | $104.27M(+12.8%) |
| Sep 2023 | - | $92.43M(+2.3%) |
| Jun 2023 | - | $90.36M(+0.6%) |
| Mar 2023 | - | $89.85M(+3.8%) |
| Dec 2022 | $289.22M(+19.8%) | $86.52M(+28.8%) |
| Sep 2022 | - | $67.18M(-11.6%) |
| Jun 2022 | - | $75.97M(+7.2%) |
| Mar 2022 | - | $70.89M(+6.2%) |
| Dec 2021 | $241.50M(+7.0%) | $66.77M(+1.7%) |
| Sep 2021 | - | $65.66M(+0.9%) |
| Jun 2021 | - | $65.06M(+16.2%) |
| Mar 2021 | - | $55.97M(-6.3%) |
| Dec 2020 | $225.67M(+15.8%) | $59.74M(-7.7%) |
| Sep 2020 | - | $64.70M(+7.4%) |
| Jun 2020 | - | $60.24M(-4.7%) |
| Mar 2020 | - | $63.18M(+8.0%) |
| Dec 2019 | $194.88M(+20.5%) | $58.51M(+6.1%) |
| Sep 2019 | - | $55.16M(+5.9%) |
| Jun 2019 | - | $52.07M(+11.8%) |
| Mar 2019 | - | $46.55M(+3.9%) |
| Dec 2018 | $161.75M(+52.1%) | $44.82M(-4.0%) |
| Sep 2018 | - | $46.70M(+5.9%) |
| Jun 2018 | - | $44.12M(+9.7%) |
| Mar 2018 | - | $40.20M(+189.2%) |
| Dec 2017 | $106.35M(+49.5%) | -$45.05M(-255.3%) |
| Sep 2017 | - | $29.01M(+26.6%) |
| Jun 2017 | - | $22.91M(-1.3%) |
| Mar 2017 | - | $23.21M(+20.8%) |
| Dec 2016 | $71.14M(+32.4%) | $19.21M(+0.4%) |
| Sep 2016 | - | $19.14M(+2.1%) |
| Jun 2016 | - | $18.75M(+16.6%) |
| Mar 2016 | - | $16.08M(+16.0%) |
| Dec 2015 | $53.73M(-0.8%) | - |
| Sep 2015 | - | $13.86M(-0.2%) |
| Jun 2015 | - | $13.89M(-7.0%) |
| Mar 2015 | - | $14.93M(+15.7%) |
| Dec 2014 | $54.17M | $12.91M(-2.9%) |
| Sep 2014 | - | $13.29M(-0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $13.40M(-26.9%) |
| Mar 2014 | - | $18.34M(+20.3%) |
| Dec 2013 | $51.85M(+31.0%) | $15.24M(+12.5%) |
| Sep 2013 | - | $13.54M(-1.8%) |
| Jun 2013 | - | $13.79M(-0.1%) |
| Mar 2013 | - | $13.80M(+10.4%) |
| Dec 2012 | $39.58M(+22.4%) | $12.50M(+33.7%) |
| Sep 2012 | - | $9.35M(+10.3%) |
| Jun 2012 | - | $8.47M(-23.2%) |
| Mar 2012 | - | $11.03M(+11.1%) |
| Dec 2011 | $32.33M(+17.8%) | $9.94M(+54.4%) |
| Sep 2011 | - | $6.43M(-27.6%) |
| Jun 2011 | - | $8.88M(+25.1%) |
| Mar 2011 | - | $7.10M(+0.1%) |
| Dec 2010 | $27.44M(+35.3%) | $7.09M(-0.1%) |
| Sep 2010 | - | $7.10M(+24.7%) |
| Jun 2010 | - | $5.70M(-6.2%) |
| Mar 2010 | - | $6.07M(+17.5%) |
| Dec 2009 | $20.28M(+1.9%) | $5.17M(+10.8%) |
| Sep 2009 | - | $4.67M(-4.4%) |
| Jun 2009 | - | $4.88M(-10.8%) |
| Mar 2009 | - | $5.47M(-13.3%) |
| Dec 2008 | $19.90M(+56.3%) | $6.31M(+12.1%) |
| Sep 2008 | - | $5.63M(+28.1%) |
| Jun 2008 | - | $4.40M(+11.9%) |
| Mar 2008 | - | $3.93M(-6.3%) |
| Dec 2007 | $12.73M(-50.8%) | $4.19M(+22.3%) |
| Sep 2007 | - | $3.43M(+91.4%) |
| Jun 2007 | - | $1.79M(-32.2%) |
| Mar 2007 | - | $2.64M(-33.1%) |
| Dec 2006 | $25.88M(+22.3%) | $3.95M(-38.3%) |
| Sep 2006 | - | $6.40M(-19.6%) |
| Jun 2006 | - | $7.96M(+16.2%) |
| Mar 2006 | - | $6.85M(+30.6%) |
| Dec 2005 | $21.16M(+31.9%) | $5.25M(+0.5%) |
| Sep 2005 | - | $5.22M(-5.2%) |
| Mar 2005 | - | $5.51M(+3.8%) |
| Dec 2004 | $16.05M(+60.9%) | $5.31M(+29.9%) |
| Sep 2004 | - | $4.09M(+14.1%) |
| Jun 2004 | - | $3.58M(+40.5%) |
| Mar 2004 | - | $2.55M(+28.2%) |
| Dec 2003 | $9.97M(-47.0%) | $1.99M(-31.0%) |
| Jun 2003 | - | $2.88M(+2.5%) |
| Mar 2003 | - | $2.81M |
| Dec 2002 | $18.80M(+134.8%) | - |
| Dec 2001 | $8.01M | - |
FAQ
- What is Corcept Therapeutics Incorporated annual total expenses?
- What is the all-time high annual total expenses for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual total expenses year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly total expenses?
- What is the all-time high quarterly total expenses for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly total expenses year-on-year change?
What is Corcept Therapeutics Incorporated annual total expenses?
The current annual total expenses of CORT is $538.09M
What is the all-time high annual total expenses for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual total expenses is $538.09M
What is Corcept Therapeutics Incorporated annual total expenses year-on-year change?
Over the past year, CORT annual total expenses has changed by +$163.00M (+43.45%)
What is Corcept Therapeutics Incorporated quarterly total expenses?
The current quarterly total expenses of CORT is $188.28M
What is the all-time high quarterly total expenses for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly total expenses is $188.28M
What is Corcept Therapeutics Incorporated quarterly total expenses year-on-year change?
Over the past year, CORT quarterly total expenses has changed by +$52.42M (+38.59%)